Estudios y Referencias de los Factores de Transferencia.-
Mucho se ha hablado de los Transfer Factor y como pueden ayudar a la Salud de cada uno de nosotros. Lo que sin duda ha despertado el interés de personas de todas las edades e incluso personas que se desempeñan en el área de Salud, Asombro es la palabra que muchos han tenido en sus bocas al saber como el mismo sistema inmunológico es Capaz de reaccionar de mejor forma ante enfermedades tan comunes como el cáncer, la leucemia, el lupus o la artritis reumatoide.
Pero ese asombro no es por casualidad, ya que el descubrimiento de estas importantes moléculas se mantuvo en boca de Inmunólogos y personas especializadas, leyéndolos en libros de inmunología y otros papers médicos segmentados pero en ningún caso en médicos generales ni en el publico en general, hasta ahora.-
Esto fue causa de que la tecnología existente en 1949 era muy precaria para Extraer moléculas tan pequeñas como los Transfer Factor (peso molecular aproximado 4400), es por eso que la medicina general se enfoco en otros descubrimientos maravillosos como los Antibióticos, vitaminas, fito nutrientes entre otros.-
No fue hasta que en 1998, David Lisonbee encontró esta patente, la cual hablaba de los factores de transferencia, descubrimiento realizado en Nueva York Por el Dr. En inmunología PHD Sherwood Lawrence en 1949. En ese año (1998) empezó la revolución de los Transfer Factor a nivel mundial.
Estudios y Referencias:
Miles son los casos en el mundo de las bondades de los factores de transferencia, miles son las personas que se han beneficiado de un sistema inmunológico, fuerte, potenciado y modulado con el cual han podido Luchar de forma natural ante tantas enfermedades comunes en estos días.
En chile muchas han sido, y el doctor Jorge Pérez que reside en Viña del Mar asi lo cuenta; “hasta el minuto he ayudado a más de 115 Pacientes con Factores de Transferencia, teniendo 115 Casos Exitosos con Cero efectos Adversos” .
Por otro Lado, El Académico e Investigador Dr. Claudio Maffed, Que dicta en la universidad de viña del mar la Cátedra de inmunología y microbiología también los recomienda y explica día a día a sus alumnos y pacientes el Beneficio de los factores de Transferencia.
Estos Relatos se Acompañan con muchos Estudios clínicos, realizados por instituciones independientes norteamericanas y Europeas sin contar las investigaciones independientes realizadas por el Transfer Factor Institute El cual fue fundado por el Dr. Sherwood Lawrence en 1949. Estudios que dan un Respaldo Serio ante médicos y Personas que se interesan por investigar los factores de Transferencia, El 1999 el Instituto de longetividad de California en un estudio que duro 7 años probando 192 productos, con los mas rigorosos estándares de pruebas para suplementos alimenticios, determino que los Factores de Transferencia Aumentan hasta un 483% la respuesta del sistema inmunológico, combatiendo de mejor manera amenazas externas como también Células Cancerigenas.
Siendo así mas de 20 Veces más poderoso que otros suplementos Naturales como Sintéticos tal como el NONI, Aloe Vera, Calostro Bovino disecado, Fito nutrientes, hongo Mitake, Hongo Shiitake como otras Sintéticas tal como la IL-2 (interleucina-2), utilizada antiguamente para tratar el cáncer y otras enfermedades por el gobierno Ruso.-
Es así que hasta el minuto hay alrededor de 3.000 estudios independientes, que no tienen que ver con la compañia 4Life (http://www.4life.com/) pero si hablan de las propiedades del factor de transferencia y como este puede ayudar de forma eficaz a combatir de forma natural diferentes enfermedades y como puede también prevenirlas, para mas información sobre estudios y otras referencias no dude en comunicarse al correo 4chile.blogspot.com
Referencias:
Referencias del PUBMED norteamericano.
Publicaciones Factores de Transferencia en Latinoamerica.
Entrevista al Dr. Sergio Parra Estrada, por Edmundo Derbez García. CIENCIA UANL / VOL. VI, No. 2, ABRIL-JUNIO 2003 , pp. 163-170. (Univ. Autónoma de Nuevo León). http://www.uanl.mx/publicaciones/ciencia-uanl/vol6/2/pdf/canal_abierto.pdf
Otras Publicaciones de los Factores de Transferencia
- 1019 1980 BRITISH JOURNAL OF OPHTHALMOLOGY 64(5):332-338
ABRAMSON A; KHAN A; TATE GW; MARTIN RG; HILL NO
IMMUNOCOMPETENCE AND TRANSFER-FACTOR THERAPY IN UVEITIS
6 3
1 221 1969 JOURNAL OF PATHOLOGY 97(3):495-&
ADAMS D; WILLIAMS.JJ; DOLBY AE
DELAYED HYPERSENSITIVITY RESPONSE IN GUINEA-PIG ORAL MUCOSA
12 0
2 669 1976 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 23(3):499-506
AHERN T; SANDERSON CJ
STIMULATION OF LYMPHOCYTES BY ANTIGEN IN MICROPLATE CULTURES - ABSENCE OF AN EFFECT OF TRANSFERFACTOR
INVITRO
5 4
2 1153 1982 INDIAN JOURNAL OF MEDICAL RESEARCH 75(MAY):734-738
AHLUWALIA N; MISRA RC; SAHA K; AGARWAL SK; GUPTA PS
DEPRESSION OF JEJUNAL IGA AND PERIPHERAL T-CELL COUNTS IN PATIENTS OF AMEBIC LIVER-ABSCESS
1 0
5 1193 1983 ARCHIVES OF DERMATOLOGY 119(11):934-945
AHMED AR; BLOSE DA
DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING - A REVIEW
27 0
4 712 1976 JOURNAL OF PEDIATRICS 88(5):751-765
ALBRECHT RM; HONG R
BASIC AND CLINICAL CONSIDERATIONS OF MONOCYTE-MACROPHAGE SYSTEM IN MAN
19 1
2 235 1970 JOURNAL OF EXPERIMENTAL MEDICINE 131(6):1049-&
ALDER WH; TAKIGUCH.T; MARSH B; SMITH RT
CELLULAR RECOGNITION BY MOUSE LYMPHOCYTES IN-VITRO .1. DEFINITION OF A NEW TECHNIQUE AND RESULTS OF
STIMULATION BY PHYTOHEMAGGLUTININ AND SPECIFIC ANTIGENS
2 0
1 266 1971 LANCET 2(7716):135-&
ALLISON AC; DENMAN AM; BARNES RD
COOPERATING AND CONTROLLING FUNCTIONS OF THYMUS-DERIVED LYMPHOCYTES IN RELATION TO AUTOIMMUNITY
615 12
29 949 1979 CANCER TREATMENT REVIEWS 6(4):209-215
ALSARRAF M; BAKER LH
TRANSFER-FACTOR
4 3
1 155 1965 PEDIATRIC CLINICS OF NORTH AMERICA 12(3):663-&
ALTEMEIE.WA; SMITH RT
IMMUNOLOGIC ASPECTS OF RESISTANCE IN EARLY LIFE
25 0
5 1467 1996 BIOTHERAPY 9(1-3):55-59
AlvarezThull L; Kirkpatrick CH
Profiles of cytokine production in recipients of transfer factors
2 2
1 829 1977 PEDIATRIC CLINICS OF NORTH AMERICA 24(2):293-311
AMMANN AJ
T-CELL AND T-B CELL IMMUNODEFICIENCY DISORDERS
12 0
2 444 1974 CELLULAR IMMUNOLOGY 12(1):94-101
AMMANN AJ; WARA D; SALMON S
TRANSFER-FACTOR - THERAPY IN PATIENTS WITH DEFICIENT CELL- MEDIATED-IMMUNITY AND DEFICIENT ANTIBODYMEDIATED
IMMUNITY
12 8
1 257 1971 CELLULAR IMMUNOLOGY 2(6):517-&
AMOS DB; YUNIS EJ
NEW INTERPRETATION OF MAJOR HISTOCOMPATIBILITY GENE COMPLEXES OF MAN AND MOUSE
33 0
1 1361 1988 CLINICAL OBSTETRICS AND GYNECOLOGY 31(2):501-509
AMSTEY MS
TREATMENT AND PREVENTION OF VIRAL-INFECTIONS (HSV, CMV, HPV, HBV)
1 0
1 81 1962 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 84(8):1096-&
ANDRESEN RH; MONROE CW
EXPERIMENTAL STUDY OF BEHAVIOR OF ADULT HUMAN SKIN HOMOGRAFTS DURING PREGNANCY - A PRELIMINARY
REPORT
65 0
7 884 1978 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 9(2):157-165
ANDRON LA; ASCHER MS
TRANSFER-FACTOR INVITRO - CHROMATOGRAPHY OF COMPONENTS THAT ENHANCE ANTIGEN-INDUCED LYMPHOCYTEPROLIFERATION
4 3
2 1015 1980 ARCHIVES OF DERMATOLOGICAL RESEARCH 269(3):291-296
ANGELINI G; VENA GA; DOVIDIO R; MENEGHINI CL
THE ACTIVE E-ROSETTE TEST IN ALLERGIC CONTACT-DERMATITIS
2 0
1 1398 1990 BAILLIERES CLINICAL GASTROENTEROLOGY 4(2):425-441
920 1978 PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY
TOXICOLOGY AND METABOLIC INHIBITORS 2(4):623-672
WAKSMAN BH
MODULATION OF IMMUNITY BY SOLUBLE MEDIATORS
27 0
6 659 1976 CELLULAR IMMUNOLOGY 21(1):161-176
WAKSMAN BH; NAMBA Y
SOLUBLE MEDIATORS OF IMMUNOLOGICAL REGULATION
235 14
1 290 1972 ANNALS OF INTERNAL MEDICINE 77(4):605-&
WALDMANN TA; STROBER W; BLAESE RM
IMMUNODEFICIENCY DISEASE AND MALIGNANCY - VARIOUS IMMUNOLOGICAL DEFICIENCIES OF MAN AND ROLE OF
IMMUNE PROCESSES IN CONTROL OF MALIGNANT DISEASE
231 13
6 544 1975 CELLULAR IMMUNOLOGY 15(2):372-381
WALKER AM; GARCIA R; PATE P; MATA LJ; DAVID JR
TRANSFER-FACTOR IN IMMUNE DEFICIENCY OF PROTEIN-CALORIE MALNUTRITION - CONTROLLED-STUDY WITH 32
CASES
16 7
4 739 1977 ACTA ENDOCRINOLOGICA 85(4):753-759
WALL JR; GRAY B; GREENWOOD DM
TOTAL AND ACTIVATED PERIPHERAL-BLOOD T-LYMPHOCYTES IN PATIENTS WITH THYROID DISORDERS
31 0
2 41 1958 JOURNAL OF IMMUNOLOGY 80(5):362-366
WALLACE JH
LEUKOCYTIC TRANSFER OF DELAYED SENSITIVITY TO NORMAL GUINEA PIGS FROM RATS INFECTED WITH
MYCOBACTERIUM-LEPRAEMURIUM
11 3
1 116 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND
MEDICINE 113(3):650-&
WALLRAFF EB
WARBURG STUDIES ON COCCIDIOIDIN
1 0
2 180 1967 JOURNAL OF INVESTIGATIVE DERMATOLOGY 48(6):553-&
WALLRAFF EB; VANLIEW RM; WAITE S
SKIN REACTIVITY AND SEROLOGICAL RESPONSE TO COCCIDIOIDIN SKIN TESTS
7 2
1 1165 1982 JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 45(6):494-
500
WALSH JC; GARRICK R; CAMERON J; MCLEOD JG
EVOKED-POTENTIAL CHANGES IN CLINICALLY DEFINITE MULTIPLE- SCLEROSIS - A 2 YEAR FOLLOW UP STUDY
33 1
1 638 1976 AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 6(6):536-539
WALTERS BAJ; RUTHERFORD JC; WALL JR
ABNORMAL ACTIVATED ROSETTE FORMATION IN PATIENTS WITH GASTROINTESTINAL CANCER
4 1
3 1253 1984 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 33(1):1-12
WANG K
EFFECT OF HUMAN-TUMOR ANTIGENS ON THE ACTIVE E-ROSETTE-FORMING TEST (ARFT) - A NEW DIAGNOSTIC
METHOD FOR CANCER
1 0
1 596 1975 NEW ENGLAND JOURNAL OF MEDICINE 292(16):869-869
WARA DW; AMMANN AJ; GOLDSTEIN AL
TRANSFER-FACTOR THYMOSIN AND E ROSETTES - REPLY
0
1 1170 1982 MEDICAL LABORATORY SCIENCES 39(1):33-38
WARD F; CAMPBELLBENZIE A; HEATH RB
FLUORESCENT-ANTIBODY TO MEMBRANE ANTIGEN (FAMA) PROCEDURE FOR DETERMINING SUSCEPTIBILITY TO
VARICELLA - AN EVALUATION
4 0
0 226 1969 SCIENCE 163(3871):1079-&
WARD PA; REMOLD HG; DAVID JR
LEUKOTACTIC FACTOR PRODUCED BY SENSITIZED LYMPHOCYTES
248 20
3 929 1978 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 116(4):507-510
WARNATZ H
IMMUNOLOGICAL ASPECTS IN DIAGNOSIS AND TREATMENT OF MALIGNANT BONE TUMORS
0
2 153 1965 MEDICINA ET PHARMACOLOGIA EXPERIMENTALIS 13(3):177-&
WARNATZ H; SCHEIFFA.F; ABOUREBY.L
SEROLOGISCHE UNTERSUCHUNGEN ZUM NACHWEIS EINES ZELLULAR FIXIERTEN ANTIKORPERS BEI DER
TRANSPLANTATIONSIMMUNITAT
2 0
1 161 1966 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY
30(3):238-&
WARNATZ H; SCHEIFFA.F; SCHMIDT G
IMMUNOLOGICAL STUDIES OF INFLUENCE OF ISOLOGOUS LYMPHOCYTES ON GROWTH OF EHRLICH-ASCITES-TUMOR
5 0
1 178 1967 JOURNAL OF IMMUNOLOGY 98(2):402-&
WARNATZ H; SCHEIFFA.F; WOLF F; SCHMIDT HJ
AUTORADIOGRAPHIC EXPERIMENTS CONCERNING IMPORTANCE OF MONONUCLEAR CELLS IN EXPERIMENTAL
HEPATITIS
12 0
1 94 1962 MEDICINA EXPERIMENTALIS 6(6):356-&
WARNATZ H; SCHEIFFARTH F; HALFAR I
EXPERIMENTELLE STUDIEN ZUR TRANSPLANTATIONSIMMUNITAT - NACHWEIS ZELLGEBUNDENER ANTIKORPER BEI
SENSIBILISIERUNG MIT HOMOLOGEN GEWEBSANTIGENEN
0
1 1137 1982 CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 9(1):27-30
WARREN KG; GORDON PA; MCPHERSON TA
PLASMA-EXCHANGE OF MALIGNANT MULTIPLE-SCLEROSIS
6 1
3 611 1975 TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND
HYGIENE 69(5-6):488-493
WARREN KS; COOK JA; DAVID JR; JORDAN P
PASSIVE TRANSFER OF IMMUNITY IN HUMAN SCHISTOSOMIASIS MANSONI - EFFECT OF TRANSFER-FACTOR ON EARLY
ESTABLISHED INFECTIONS
2 0
2 172 1967 AMERICAN JOURNAL OF PATHOLOGY 51(5):735-&
WARREN KS; DOMINGO EO; COWAN RBT
GRANULOMA FORMATION AROUND SCHISTOSOME EGGS AS A MANIFESTATION OF DELAYED HYPERSENSITIVITY
365 0
3 1217 1983 JOURNAL OF IMMUNOLOGY 130(1):237-241
WARRINGTON RJ; SAUDER PJ; OLIVIER SL; RUTHERFORD WJ; WILKINS JA
A HUMAN T-CELL-DERIVED SOLUBLE FACTOR ABLE TO SUPPRESS POKEWEED MITOGEN-INDUCED IMMUNOGLOBULIN
PRODUCTION
30 1
1 62 1960 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 56(1):139-147
WARWICK WJ; GOOD RA; SMITH RT
FAILURE OF PASSIVE TRANSFER OF DELAYED HYPERSENSITIVITY IN THE NEWBORN HUMAN INFANT
33 5
2 17 1956 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND
MEDICINE 93(2):253-255
WARWICK WJ; PAGE A; GOOD RA
PASSIVE TRANSFER WITH CIRCULATING LEUKOCYTES OF DELAYED HYPERSENSITIVITY TO CAT SCRATCH ANTIGEN
15 7
4 160 1966 GASTROENTEROLOGY 51(6):985-&
WATSON DW; QUIGLEY A; BOLT RJ
EFFECT OF LYMPHOCYTES FROM PATIENTS WITH ULCERATIVE COLITIS ON HUMAN ADULT COLON EPITHELIAL CELLS
124 0
2 144 1965 GASTROENTEROLOGY 49(6):649-&
WATSON DW; STYLER HJ; BOLT RJ
AUTOLOGOUS LEUKOCYTE SKIN TEST IN PATIENTS WITH ULCERATIVE COLITIS
20 1
4 1290 1985 ANNALS OF ALLERGY 55(5):654-&
WATSON RD; GERSHWIN ME; SMITHWICK E; CASTLES JJ; RUEBNER B
CUTANEOUS T-CELL LYMPHOMA AND LEUKOCYTOCLASTIC VASCULITIS IN A LONG-TERM SURVIVOR OF WISKOTTALDRICH
SYNDROME
6 0
3 997 1979 JOURNAL OF SURGICAL ONCOLOGY 12(3):213-220
WEBSTER DJT; CORNACOFF JB; VALLERA DA; DALMASSO JP; DODD MC; MINTON JP
IMMUNOTHERAPY OF A MURINE SARCOMA USING SPECIFIC ANTI-TUMOR IMMUNE RNA
1 0
1 286 1972 AMERICAN REVIEW OF RESPIRATORY DISEASE 105(5):845-&
WEGNER TN; TRAUTMAN RJ; BEAVERS CD; REED RE
EVIDENCE FOR DEVELOPMENT OF A PHAGOCYTIC RESPONSE BY POLYMORPHONUCLEAR LEUKOCYTES RECOVERED
FROM VENOUS-BLOOD OF DOGS INOCULATED WITH COCCIDIOIDES-IMMITIS OR VACCINATED WITH AN IRRADIATED
SPHERULE VACCINE
7 0
1 1265 1984 JOURNAL OF INFECTIOUS DISEASES 149(5):741-749
WEIGLE KA; GROSE C
MOLECULAR DISSECTION OF THE HUMORAL IMMUNE-RESPONSE TO INDIVIDUAL VARICELLA-ZOSTER VIRAL-PROTEINS
DURING CHICKENPOX, QUIESCENCE, REINFECTION, AND REACTIVATION
60 0
0 394 1973 NOUVELLE PRESSE MEDICALE 2(34):2271-2273
WEILL B
RECENT WORK ON IMMUNE DEFICIENCIES IN MAN
0
0 756 1977 CANCER IMMUNOLOGY IMMUNOTHERAPY 2(1):11-19
WEISS DW
QUESTIONABLE IMMUNOGENICITY OF CERTAIN NEOPLASMS - WHAT THEN PROSPECTS FOR IMMUNOLOGICAL
INTERVENTION IN MALIGNANT DISEASE
61 2
2 352 1973 CELLULAR IMMUNOLOGY 7(2):222-236
WEISSMAN I; LANNIN D; JERABEK L; BARCLAY T
CELLULAR IMMUNITY TO HETEROLOGOUS ERYTHROCYTES IN-VITRO .1. ROLE OF SURFACE-ADHERENT CELLS AND
SPECIFIC MEDIATORS IN AN EFFECTOR MECHANISM
27 0
16 675 1976 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 5(3):407-415
WELCH TM; TRIGLIA R; SPITLER LE; FUDENBERG HH
PRELIMINARY STUDIES ON HUMAN TRANSFER-FACTOR ACTIVITY IN GUINEA-PIGS - SYSTEMIC TRANSFER OF CUTANEOUS
DELAYED-TYPE HYPERSENSITIVITY TO PPD AND SKSD
35 28
1 568 1975 IMMUNOCHEMISTRY 12(6-7):485-489
WELIKY N
REFLECTIONS ON SOME ASPECTS OF CHEMISTRY IN IMMUNOCHEMISTRY - MOLECULAR DISCRIMINATION AND
DETERMINATION
1 0
3 1223 1983 NEW ENGLAND JOURNAL OF MEDICINE 309(23):1434-1440
WELLER TH
147 3
VARICELLA AND HERPES-ZOSTER - CHANGING CONCEPTS OF THE NATURAL- HISTORY, CONTROL, AND IMPORTANCE OF
A NOT-SO-BENIGN VIRUS .2.
1 360 1973 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 1(2):257-291
WELLS JV; BLEUMERS JF; FUDENBER.HH
IMMUNOBIOLOGY OF HUMAN ANTI-IGM ISOANTIBODIES .1. CLINICAL AND SEROLOGICAL STUDIES
9 1
11 424 1974 AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 4(4):396-411
WELLS JV; FUDENBER.HH
MANAGEMENT OF PATIENTS WITH PRIMARY IMMUNE DEFICIENCY SYNDROMES
2 0
5 845 1977 ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY 153(5):380-
394
WENZEL B; AVERDUNK R
DIFFERENTIATION BETWEEN VARIOUS EFFECTS OF CYTOTOXIC FRACTIONS OF LYMPHOCYTE CULTURE MEDIUM
0
3 780 1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(1):73-79
WENZEL KL; ICHIKI AT
SUBPOPULATION OF T CELLS DETECTED BY AET-TREATED SHEEP ERYTHROCYTES
13 0
3 752 1977 BULLETIN DE L INSTITUT PASTEUR 75(1):5-84
WERNER GH; MARAL R; FLOCH F; JOUANNE M
TOXICOLOGICAL ASPECTS OF IMMUNOPOTENTIATION BY ADJUVANTS AND IMMUNOSTIMULATING SUBSTANCES
17 0
2 810 1977 JOURNAL OF IMMUNOLOGY 119(2):548-554
WEST WH; PAYNE SM; WEESE JL; HERBERMAN RB
HUMAN T LYMPHOCYTE SUBPOPULATIONS - CORRELATION BETWEEN E- ROSETTE-FORMING AFFINITY AND EXPRESSION
OF FC RECEPTOR
139 6
2 457 1974 EXPERIMENTAL HEMATOLOGY 2(2):73-82
WETTER O; VANDEWEE.M; REIS HE; LEINER G
MITOGENIC STIMULATION OF HUMAN LEUKEMIC PLASMA-CELLS
6 0
11 968 1979 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 13(3):287-295
WHITACRE CC; PATERSON PY
GUINEA-PIG TRANSFER-FACTOR - RESTRICTION OF MACROPHAGE- MIGRATION INHIBITORY ACTIVITY TO
EXTRAORDINARY DILUTION CONFIRMED WITH DEMONSTRATION OF DIMINISHED POTENCY OF STORED PREPARATIONS
4 4
0 1047 1980 JOURNAL OF IMMUNOLOGY 124(4):1784-1788
WHITACRE CC; PATERSON PY
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS SUPERNATANT TRANSFER ACTIVITY (EAE-STA) IN LEWIS RATS -
IMMUNOBIOLOGIC AND INITIAL BIOCHEMICAL-PROPERTIES
10 1
3 338 1973 ANNALS OF INTERNAL MEDICINE 79(2):161-166
WHITCOMB ME; ROCKLIN RE
TRANSFER FACTOR THERAPY IN A PATIENT WITH PROGRESSIVE PRIMARY TUBERCULOSIS
55 36
1 1166 1982 JOURNAL OF PEDIATRICS 101(1):125-131
WHITLEY R; HILTY M; HAYNES R; BRYSON Y; CONNOR JD; SOONG SJ; ALFORD CA
VIDARABINE THERAPY OF VARICELLA IN IMMUNOSUPPRESSED PATIENTS
86 6
2 1421 1992 JOURNAL OF INFECTIOUS DISEASES 166():S51-S57
WHITLEY RJ
THERAPEUTIC APPROACHES TO VARICELLA-ZOSTER VIRUS-INFECTIONS
20 0
1 913 1978 MEDICAL JOURNAL OF AUSTRALIA 1(10):569-570
WHITTINGHAM S; SHARMA DLB
LEVAMISOLE - LACK OF IMMUNOPOTENTIATION IN A CONTROLLED TRIAL
2 0
1 846 1977 ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE
SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY
PARASITOLOGY 239(3):379-396
WILHELM G; ROMER C; WINZKOWSKI M; NOWSCHAK R
INVESTIGATION OF A NEWLY ISOLATED OLIGOPEPTIDE FROM MYCOBACTERIUM-TUBERCULOSIS WITH ANTIGENIC
PROPERTIES SPECIFIC FOR DIAGNOSIS OF TUBERCULOSIS
4 0
12 1043 1980 INFECTION AND IMMUNITY 27(1):187-191
WILLIAMS ME; KAUFFMAN CA
TRANSFER-FACTOR - MURINE MODEL
7 4
5 995 1979 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 93(5):818-837
WILSON GB; FUDENBERG HH
EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS WITH TRANSFER-FACTOR ACTIVITY ON LEUKOCYTE MIGRATION
INVITRO .2. SEPARATION AND PARTIAL CHARACTERIZATION OF THE COMPONENTS IN DLE PRODUCING ANTIGENDEPENDENT
AND ANTIGEN-INDEPENDENT EFFECTS
0
18 1212 1983 IMMUNOLOGY TODAY 4(6):157-161
WILSON GB; FUDENBERG HH
IS CONTROVERSY ABOUT TRANSFER-FACTOR THERAPY NEARING AN END
10 7
16 994 1979 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 93(5):800-818
WILSON GB; FUDENBERG HH; HORSMANHEIMO M
EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS WITH TRANSFER-FACTOR ACTIVITY ON LEUKOCYTE MIGRATION
INVITRO .1. ANTIGEN-DEPENDENT INHIBITION AND ANTIGEN-INDEPENDENT INHIBITION AND ENHANCEMENT OF
MIGRATION
24 17
5 1262 1984 JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY 13(2):51-58 4 3
WILSON GB; FUDENBERG HH; KELLER RH
GUIDELINES FOR IMMUNOTHERAPY OF ANTIGEN-SPECIFIC DEFECTS WITH TRANSFER-FACTOR
5 1143 1982 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 23(2):478-491
WILSON GB; METCALF JF; FUDENBERG HH
TREATMENT OF MYCOBACTERIUM-FORTUITUM PULMONARY INFECTION WITH TRANSFER-FACTOR (TF) - NEW
METHODOLOGY FOR EVALUATING TF POTENCY AND PREDICTING CLINICAL-RESPONSE
14 9
15 955 1979 CELLULAR IMMUNOLOGY 47(1):1-18
WILSON GB; NEWELL RT; BURDASH NM
BOVINE DIALYZABLE LYMPH-NODE EXTRACTS HAVE ANTIGEN-DEPENDENT AND ANTIGEN-INDEPENDENT EFFECTS ON
HUMAN CELL-MEDIATED-IMMUNITY INVITRO
7 7
0 972 1979 CLINICAL RESEARCH 27(5):A750-A750
WILSON GB; NEWELL RT; PADDOCK GV; BURDASH NM; FUDENBERG HH
PURIFICATION OF 2 HUMAN THYMUS-DERIVED LYMPHOCYTE MATURATION FACTORS FROM BOVINE LYMPH-NODE AND
HUMAN MONONUCLEAR LEUKOCYTE EXTRACTS
0
4 1278 1984 THYMUS 6(3):167-180
WILSON GB; PADDOCK GV; FLOYD E; NEWELL RT; DOPSON MH
DIALYZABLE LEUKOCYTE EXTRACTS CONTAIN THYMOSIN
1 0
8 1119 1981 THYMUS 2(4-5):257-276
WILSON GB; PADDOCK GV; FUDENBERG HH
EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS WITH TRANSFER-FACTOR ACTIVITY ON LEUKOCYTE MIGRATION
INVITRO .5. ANTIGEN-SPECIFIC LYMPHOCYTE RESPONSIVENESS CAN BE INITIATED BY 2 STRUCTURALLY DISTINCT
POLYRIBONUCLEOPEPTIDES
12 8
10 1181 1982 THYMUS 4(6):335-350
WILSON GB; PADDOCK GV; FUDENBERG HH
BOVINE TRANSFER-FACTOR - AN OLIGORIBONUCLEOPEPTIDE WHICH INITIATES ANTIGEN-SPECIFIC LYMPHOCYTES
RESPONSIVENESS
9 4
10 987 1979 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 64(1):56-66
WILSON GB; SMITH CL; FUDENBERG HH
EFFECTS OF DIALYZABLE LEUKOCYTE EXTRACTS (DLES) WITH TRANSFER- FACTOR ACTIVITY ON LEUKOCYTE
MIGRATION INVITRO .3. CHARACTERIZATION OF THE ANTIGEN-INDEPENDENT MIGRATION- INHIBITION FACTOR IN DLES
AS A NEUTROPHIL IMMOBILIZING FACTOR
9 5
11 774 1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 7(2):187-202
WILSON GB; WELCH TM; FUDENBERG HH
TX - COMPONENT IN HUMAN DIALYZABLE TRANSFER-FACTOR THAT INDUCES CUTANEOUS DELAYED-HYPERSENSITIVITY
IN GUINEA-PIGS
13 11
11 784 1977 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 8(3):551-568
WILSON GB; WELCH TM; KNAPP DR; HORSMANHEIMO A; FUDENBERG HH
CHARACTERIZATION OF TX, AN ACTIVE SUBFRACTION OF HUMAN DIALYZABLE TRANSFER-FACTOR .1. IDENTIFICATION
OF MAJOR COMPONENT IN TFG, A PRECURSOR OF TX, AS HYPOXANTHINE
26 20
4 635 1976 ARCHIVES OF INTERNAL MEDICINE 136(3):343-346
WILSON WR; HERMANS PE; RITTS RE
IDIOPATHIC LATE-ONSET IMMUNOGLOBULIN DEFICIENCY WITH FUNCTIONAL T-CELL DEFICIENCY
4 0
6 842 1977 WESTERN JOURNAL OF MEDICINE 126(1):14-31
WING EJ; REMINGTON JS
CELL-MEDIATED-IMMUNITY AND ITS ROLE IN RESISTANCE TO INFECTION
15 0
1 1254 1984 CUTIS 34(3):278-281
WINKELMANN RK; DEREMEE RA; RITTS RE
TREATMENT OF VARICELLA-ZOSTER PNEUMONIA WITH TRANSFER-FACTOR
3 0
1 636 1976 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 100(5):283-286
WISE WS; STILL WJS; JOSHI VV
SEVERE COMBINED IMMUNODEFICIENCY WITH THYMIC MAST-CELL HYPERPLASIA
3 0
1 618 1975 VOX SANGUINIS 29(5):352-362
WIT JJFMD; HENRICHS HJP; ODINK J; PRINS HK
EXPERIMENTS ON PREPARATION OF BLOOD COMPONENTS WITH IBM 2991 BLOOD-CELL PROCESSOR
4 0
2 1183 1982 TRANSPLANTATION 33(2):143-149
WITHERSPOON RP; KOPECKY K; STORB RF; FLOURNOY N; SULLIVAN KM; SOSA R; DEEG HJ; OCHS HD; CHEEVER MA;
FEFER A; THOMAS ED
IMMUNOLOGICAL RECOVERY IN 48 PATIENTS FOLLOWING SYNGENEIC MARROW TRANSPLANTATION FOR
HEMATOLOGICAL MALIGNANCY
89 0
1 1353 1987 PEDIATRIC HEMATOLOGY AND ONCOLOGY 4(4):345-348
WODZINSKI MA; LILLEYMAN JS
HIGH-DOSE IMMUNOGLOBULIN THERAPY OF WISKOTT ALDRICH SYNDROME
3 0
3 1484 1998 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 12(4):835-+
Wolchok JD; Livingston PO; Houghton AN
Vaccines and other adjuvant therapies for melanoma
6 0
1 887 1978 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 10(3):292-297
WOLF RE; FUDENBERG HH; GILLIAM JN
TRANSFER-FACTOR THERAPY IN A CASE OF PEMPHIGUS VEGETANS ASSOCIATED WITH CHRONIC MUCOCUTANEOUS
CANDIDIASIS
2 2
2 800 1977 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 238(8):869-871
WOLF RE; FUDENBERG HH; WELCH TM; SPITLER LE; ZIFF M
TREATMENT OF BECHCETS SYNDROME WITH TRANSFER-FACTOR
30 3
2 193 1968 BIOCHEMICAL PHARMACOLOGY S():87-&
WOLFJURG.P
INFLAMMATORY EXUDATE IN DELAYED HYPERSENSITIVITY
0
1 145 1965 GUT 6(3):221-&
WOLFJURG.P; ANTHONIS.P; RIIS P
CUTANEOUS ABACTERIAL INFLAMMATORY REACTION IN PATIENTS WITH ULCERATIVE COLITIS
5 0
2 960 1979 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 35(3):397-404
WOLINSKY JS; DAU PC; BUIMOVICIKLEIN E; MEDNICK J; BERG BO; LANG PB; COOPER LZ
PROGRESSIVE RUBELLA PANENCEPHALITIS - IMMUNO-VIROLOGICAL STUDIES AND RESULTS OF ISOPRINOSINE THERAPY
20 0
1 423 1974 ARCHIVES OF OPHTHALMOLOGY 92(4):335-339
WONG VG; KIRKPATR.CH
IMMUNE RECONSTITUTION IN KERATOCONJUNCTIVITIS AND SUPERFICIAL CANDIDIASIS - ROLE OF
IMMUNOCOMPETENT LYMPHOCYTE TRANSFUSION AND TRANSFER-FACTOR
3 1
6 1065 1980 RECENT RESULTS IN CANCER RESEARCH 75():180-184
WYBRAN J
LYNESTRENOL - A PROGESTERONE-LIKE AGENT WITH IMMUNOSTIMULATORY PROPERTIES
4 0
14 1128 1982 ANNALES D IMMUNOLOGIE D133(2):211-218
WYBRAN J; DUPONT E
THE ACTIVE T-ROSETTE - AN EARLY MARKER FOR T-CELL ACTIVATION
24 0
2 1204 1983 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 27(1):51-55
WYBRAN J; DUPONT E
THE ACTIVE ROSETTE MIXED-LYMPHOCYTE REACTION - AN EARLY MARKER OF LYMPHOCYTE-ACTIVATION LINKED TO
HLA-D-DR DIFFERENCES
8 0
4 1232 1983 TRANSPLANTATION PROCEEDINGS 15(1):109-112
WYBRAN J; DUPONT E
THE ACTIVE MIXED LYMPHOCYTE-REACTION - A RAPID TOOL FOR INVESTIGATING THE HLA-DR REGION
0
3 419 1974 ANNALS OF INTERNAL MEDICINE 80(6):764-767
WYBRAN J; FUDENBER.H
HOW CLINICALLY USEFUL IS T AND B-CELL QUANTITATION
0
1 389 1973 NEW ENGLAND JOURNAL OF MEDICINE 288(20):1072-1073
WYBRAN J; FUDENBER.HH
THYMUS-DERIVED ROSETTE-FORMING CELLS
167 44
10 885 1978 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 9(2):240-247
WYBRAN J; GOVAERTS A
ROSETTING FACTOR OF HUMAN MIXED LYMPHOCYTE-CULTURES
13 7
6 906 1978 JOURNAL OF IMMUNOLOGY 121(3):1184-1187
WYBRAN J; GOVAERTS A; APPELBOOM T
INOSIPLEX, A STIMULATING AGENT FOR NORMAL HUMAN T-CELLS AND HUMAN LEUKOCYTES
85 7
6 797 1977 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY
55(1-6):148-151
WYBRAN J; GOVAERTS A; FUDENBERG H
DIFFERENTIAL EFFECT OF VINBLASTINE AND COLCHICINE ON HUMAN ACTIVE AND TOTAL T ROSETTES
5 2
8 984 1979 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 1(2):151-155
WYBRAN J; GOVAERTS A; VANDAM D; APPELBOOM T
STIMULATING PROPERTIES OF LYNESTRENOL ON NORMAL HUMAN-BLOOD LYMPHOCYTES-T AND OTHER LEUKOCYTES
5 0
3 516 1975 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 249(FEB28):300-309
WYBRAN J; LEVIN AS; FUDENBERG HH; GOLDSTEIN AL
THYMOSIN - EFFECTS ON NORMAL HUMAN-BLOOD T-CELLS
58 15
3 386 1973 NEW ENGLAND JOURNAL OF MEDICINE 288(14):710-713
WYBRAN J; LEVIN AS; SPITLER LE; FUDENBER.HH
ROSETTE-FORMING CELLS, IMMUNOLOGICAL DEFICIENCY DISEASES AND TRANSFER FACTOR
278 278
3 656 1976 CANCER IMMUNOLOGY IMMUNOTHERAPY 1(3):153-156
WYBRAN J; SPITLER LE; LIEBERMAN R; FUDENBERG HH
ACTIVE T-CELLS ROSETTES AND TOTAL T-ROSETTES IN PATIENTS WITH MELANOMA FOLLOWING INTRATUMORAL
INOCULATION OF BCG - CLUE TO MECHANISM OF ACTION OF BACILLUS CALMETTE-GUERIN
13 6
1 1249 1984 CELLULAR IMMUNOLOGY 84(1):206-209
YAMADA A; HIMENO K; KUMAZAWA Y; NOMOTO K
ANTIGEN-SPECIFIC AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY A HUMORAL FACTOR IN THE CULTURE
SUPERNATANT OF IMMUNE SPLEEN-CELLS
14 1
2 1252 1984 CELLULAR IMMUNOLOGY 88(1):184-192
YAMADA A; HIMENO K; MIYATA H; KUMAZAWA Y; NOMOTO K
ANTIGEN-SPECIFIC AUGMENTATION FACTOR INVOLVED IN MURINE DELAYED-TYPE FOOTPAD REACTION .1. NATURE OF
AUGMENTATION FACTOR
12 0
4 1197 1983 BRITISH JOURNAL OF SURGERY 70(5):267-274 29 0
YAMADA N; KOYAMA H; HIOKI K; YAMADA T; YAMAMOTO M
EFFECT OF POSTOPERATIVE TOTAL PARENTERAL-NUTRITION (TPN) AS AN ADJUNCT TO GASTRECTOMY FOR ADVANCED
GASTRIC-CARCINOMA
1 1271 1984 METABOLIC BONE DISEASE & RELATED RESEARCH 5(2):53-60
YOUNG JWR; GALBRAITH M; CUNNINGHAM J; ROOF BS; VUJIC I; GOBIEN RP; LIEBSCHER L; BUTLER WM;
FUDENBERG HH
PROGRESSIVE VERTEBRAL COLLAPSE IN DIFFUSE ANGIOMATOSIS
1 0
0 743 1977 ACTA NEUROLOGICA SCANDINAVICA 55():239-251
ZABRISKIE JB; ESPINOZA LR; PLANK CR; COLLINS RC
CELL-MEDIATED IMMUNITY TO VIRAL-ANTIGENS IN MULTIPLE-SCLEROSIS
6 1
2 1356 1988 ACTA VIROLOGICA 32(3):243-251
ZACHAR V; MAYER V; SCHMIDTMAYEROVA H
VARICELLA-ZOSTER VIRUS IGG ANTIBODIES DURING PRIMOINFECTION IN COMPETENT AND TRANSFER-FACTOR
MODULATED IMMUNOCOMPROMISED HOST - COMPARISON OF 3 INDIRECT ASSAYS
1 1
2 1039 1980 DERMATOLOGICA 160(1):1-6
ZACHARIAE H; ELLEGAARD J; GRUNNET E; THESTRUPPEDERSEN K
TRANSFER-FACTOR IN MYCOSIS-FUNGOIDES - 3 YEARS EXPERIENCE
12 3
2 1309 1985 JOURNAL OF CLINICAL INVESTIGATION 75(3):1023-1027
ZALEZNIK DF; FINBERG RW; SHAPIRO ME; ONDERDONK AB; KASPER DL
A SOLUBLE SUPPRESSOR T-CELL FACTOR PROTECTS AGAINST EXPERIMENTAL INTRAABDOMINAL ABSCESSES
26 0
5 546 1975 CELLULAR IMMUNOLOGY 15(2):475-478
ZANELLI JM; ADLER WH
TRANSFER-FACTOR - TRANSFER OF TUBERCULIN CUTANEOUS SENSITIVITY IN AN ALLOGENEIC AND XENOGENEIC
MONKEY MODEL
18 14
12 1248 1984 CELLULAR IMMUNOLOGY 84(1):200-205
ZIELINSKI CC; SAVOINI E; CIOTTI M; ORANI R; KONIGSWIESER H; EIBL MM
DIALYZABLE LEUKOCYTE EXTRACT (TRANSFER-FACTOR) IN THE TREATMENT OF SUPERINFECTED FISTULATING
TUBERCULOSIS OF THE BONE
3 1
2 572 1975 JOHNS HOPKINS MEDICAL JOURNAL 136(6):243-250
ZIZIC TM; STEVENS MB
ARTHROPATHY OF BEHCETS DISEASE
29 0
5 605 1975 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 105(52):1805-1814
ZORTEACAFLISCH C; ODERMATT B; RUTTNER JR; GROB PJ
DIAGNOSTIC IMPORTANCE OF IMMUNOLOGICAL DIFFERENTIATION OF CIRCULATING LYMPHOCYTES
1 0
4 1272 1984 MYCOPATHOLOGIA 84(2-3):87-93
ZOUALI M; DROUHET E; EYQUEM A
EVALUATION OF AUTOANTIBODIES IN CHRONIC MUCOCUTANEOUS CANDIDIASIS WITHOUT ENDOCRINOPATHY
6 0
8 1426 1992 PARASITOLOGY TODAY 8(1):24-27
ZU SX; FANG GD; FAYER R; GUERRANT RL
CRYPTOSPORIDIOSIS - PATHOGENESIS AND IMMUNOLOGY
32 1
8 467 1974 JOURNAL OF CLINICAL INVESTIGATION 54(4):997-1000
ZUCKERMA.KS; NEIDHART JA; BALCERZA.SP; LOBUGLIO AF
IMMUNOLOGICAL SPECIFICITY OF TRANSFER-FACTOR
58 0
3 1425 1992 PARASITOLOGY 105():S93-S101
ZUMLA A; CROFT SL
CHEMOTHERAPY AND IMMUNITY IN OPPORTUNISTIC PARASITIC INFECTIONS IN AIDS
11 0
2 218 1969 JOURNAL OF IMMUNOLOGY 102(5):1284-&
ZWEIMAN B; PAPPAGIA.D; MAIBACH H; HILDRETH EA
COCCIDIODIDIN DELAYED HYPERSENSITIVITY - SKIN TEST AND IN VITRO LYMPHOCYTE REACTIVITIES
38 4
1 182 1967 LANCET 2(7527):1191-&
[Anon]
IMMUNOLOGY AND CANCER
0
3 205 1968 NEW ENGLAND JOURNAL OF MEDICINE 278(6):333-&
[Anon]
TRANSFER FACTOR AND LEPROSY
0
1 254 1971 BULLETIN OF THE WORLD HEALTH ORGANIZATION 45(1):125-&
[Anon]
PRIMARY IMMUNODEFICIENCIES
0
1 272 1971 MEDICAL JOURNAL OF AUSTRALIA 2(22):1102-&
[Anon]
IMMUNODEFICIENCIES IN CHILDREN
0
10 379 1973 LANCET 2(7820):79-81
[Anon]
TRANSFER FACTOR
0
11 429 1974 BRITISH MEDICAL JOURNAL 2(5916):397-398
[Anon]
TRANSFER-FACTOR
0
4 629 1976 ANNALS OF INTERNAL MEDICINE 84(4):505-509
[Anon]
ALLERGY AND CLINICAL IMMUNOLOGY - ANNOTATED-BIBLIOGRAPHY OF RECENT LITERATURE - REFERENCES TO
JOURNAL ARTICLES AND OTHER PAPERS
0
3 637 1976 ARTHRITIS AND RHEUMATISM 19(6):973-&
[Anon]
22ND RHEUMATISM REVIEW - REVIEW OF AMERICAN AND ENGLISH LITERATURE FOR YEARS 1973 AND 1974
0
4 654 1976 CANCER 37(4):2029-2148
[Anon]
RESEARCH PLAN FOR RADIATION ONCOLOGY
0
1 1068 1980 SOUTH AFRICAN MEDICAL JOURNAL 58(13):505-506
[Anon]
TRANSFER-FACTOR AND LEUKEMIA
0
3 1109 1981 MEDICAL JOURNAL OF AUSTRALIA 1(1):1-3
[Anon]
IMMUNOLOGICAL APPROACHES TO THERAPY IN MULTIPLE-SCLEROSIS
0
3 1116 1981 SOUTH AFRICAN MEDICAL JOURNAL 59(11):358-358
[Anon]
TRANSFER-FACTOR
0
1 1117 1981 SOUTH AFRICAN MEDICAL JOURNAL 59(14):473-
